Other animal studies have revealed that the introduction of APOE-ε4 in 5xFAD Alzheimer’s disease mice is linked to BBB impairment and decreased CBF, mediated by the up-regulation of cyclophilin-A-metalloproteinase-9 signaling within pericytes. Here, APOE is linked to Alzheimer disease.